The prognostic significance of immunohistochemically detected p53 protein expression in non-small cell lung cancer treated with radiation therapy

Anticancer Research

Volumn 18, Issue 5 B, 1998, Pages 3685-3688

  Hayakawa, Kazushige ^a   Mitsuhashi, Norio ^a   Hasegawa, Masatoshi ^a   Saito, Yoshihiro ^a   Sakurai, Hideyuki ^a   Ohno, Tatsuya ^a   Maebayashi, Katsuya ^a   Ebara, Takeshi ^a   Hayakawa, Kayoko Y ^a   Niibe, Hideo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Non small cell lung cancer; p53 expression; Radiation therapy; Radiosensitivity

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; BRONCHOSCOPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031701801     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991.
2. Levine AJ, Momand J and Finlay CA: The p53 tumor suppressor gene. Nature 351: 453-456, 1991.
3. Sabichi AL and Birrer MJ: The molecular biology of lung cancer: application to early detection and prevention. Oncology 7: 19-26, 1993.
4. Horio Y, Takahashi T, Kuroishi T, Hibi K, Suyama M, Niimi T, Shimokata K, Yamakawa K, Nakamura Y, Ueda R and Takahashi T: Prognostic significance of p53 mutations and 3p deletions in primary resected non-small lung cancer. Cancer Res 53: 1-4, 1993.
5. Quinlan DC, Davidson AG, Summers CL, Warden HE and Doshi HM: Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 52: 4828-4831, 1992.
6. Fujino M, Dosaka-Akita H, Harada M, Hiroumi H, Kinoshita I, Akie K and Kawakami Y: Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer. Cancer 76: 2457-2463, 1995.
7. McLaren R, Kuzu I, Dunnill M, Harris A, Lane D and Gatter KC: The relationship of p53 immunostaining to survival in carcinoma of the lung. Br J Cancer 66: 735-738, 1992.
8. Mitsudori T, Steinberg SM, Nau MM, Carbone D, D'Amico D, Bodner S, Oie HK, Linnoila RI, Mulshine JL, Minna JD and Gazdar AF: p53 gene mutations in non-small cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7: 171-180, 1992.
9. Lee JM and Bernstein A: p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA 90: 5742-5746, 1993.
10. McIlwrath AJ, Vasey PA, Ross GM and Brown R: Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res 54: 3718-3722, 1994.
11. Hasegawa M, Mitsuhashi N, Yamakawa M, Furuta M, Maebayashi K, Imai R, Hayakawa K and Niibe H: p53 protein expression and radiation-induced apoptosis in human tumors transplanted to nude mice. Radiat Med 15: 171-176, 1997.
12. Mitsuhashi N, Ishikawa H, Saito Y, Takahashi T, Sakurai H, Nozaki M, Akimoto T, Hasegawa M, Maebayashi K and Niibe H: A quantitative study of radiation-induced apoptosis in two rat yolk sac tumour cell lines with different radiosensitivities in vitro. Anticancer Res 17: 3605-3608, 1997.
13. Langendijk JA, Thunnissen FBJM, Lamers RJS, de Jong JMA, ten Velde GPM and Wouters EFM: The prognostic significance of accumulation of p53 protein in stage III non-small cell lung cancer treated by radiotherapy. Radiother Oncol 36: 218-224, 1995.
14. Safran H, King T, Choy H, Gollerkeri A, Kwakwa H, Lopez F, Cole B, Myers J, Tarpey J and Rosmarin A: p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma. Cancer 78: 1203-1210, 1996.
15. Hayakawa K, Mitsuhashi N, Saito Y, Furuta M, Nakayama Y, Katano S, Sakurai H, Takahashi T, Mitomo O and Niibe H: Impact of tumor extent and location on treatment outcome in patients with stage III non-small cell lung cancer treated wtih radiation therapy. Jpn J Clin Oncol 26: 221-228, 1996.
16. Ebara T, Mitsuhashi N, Saito Y, Sakurai H, Hasegawa M, Takahashi M, Takahashi T, Hayakawa K and Niibe H: Prognostic significance of immunohistochemically detected p53 protein expression in stage IIIB squamous cell carcinoma of the uterine cervix treated with radiation therapy alone. Gynecol Oncol 63: 216-218, 1996.
17. Olson DC and Levine AJ: The properties of p53 proteins selected for the loss of suppression of transformation. Cell Growth Differ 5: 61-71, 1994.
18. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE and Jacks T: p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810, 1994.
19. Pomp J, Davelaar J, Blom J, van Krimpen C, Zwinderman A, Quint W and Immerzeel J: Radiotherapy for oesophagus carcinoma: the impact of p53 on treatment outcome. Radiother Oncol 46: 179-184, 1998.